Search Results - Vineyard, Julie V

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice

    The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice by Hebbel, Robert P., Vercellotti, Gregory M., Pace, Betty S., Solovey, Anna N., Kollander, Rahn, Abanonu, Chine F., Nguyen, Julia, Vineyard, Julie V., Belcher, John D., Abdulla, Fuad, Osifuye, Shadé, Eaton, John W., Kelm, Robert J., Slungaard, Arne

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease

    Heme oxygenase-1 gene delivery by Sleeping Beauty inhibits vascular stasis in a murine model of sickle cell disease by Belcher, John D., Vineyard, Julie V., Bruzzone, Carol M., Chen, Chunsheng, Beckman, Joan D., Nguyen, Julia, Steer, Clifford J., Vercellotti, Gregory M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Heme Oxygenase-1 Gene Therapy in a Murine Model of Sickle Cell Disease

    Heme Oxygenase-1 Gene Therapy in a Murine Model of Sickle Cell Disease by Belcher, Belcher D., Vineyard, Julie V., Bruzzone, Carol M, Chen, Chunsheng, Beckman, Joan D, Ngyuen, Julia, Steer, Clifford J, Vercellotti, Gregory M.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease

    The HDAC Inhibitors Trichostatin A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) Exhibit Multiple Modalities of Benefit for the Vascular Pathology of Sickle Disease by Hebbel, Robert P, Vercellotti, Gregory M., Pace, Betty, Solovey, Anna, Kollander, Rahn, Abanonu, Chine, Nguyen, Julia, Vineyard, Julie V., Belcher, John D, Abdulla, Fuad, Osifuye, Shade, Eaton, John W., Kelm, Robert, Slungaard, Arne

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Carbon Monoxide Decreases Leukocytosis in Murine Sickle Cell Disease Models Via Decreased Granulopoiesis

    Carbon Monoxide Decreases Leukocytosis in Murine Sickle Cell Disease Models Via Decreased Granulopoiesis by Beckman, Joan D, Vineyard, Julie V., Chen, Chunsheng, Ngyuen, Julia, Nwaneri, Michael O, Marker, Paul, Belcher, John D., Vercellotti, Gregory M.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Inhaled Carbon Monoxide: An Anti-Inflammatory Modulator in Transgenic Sickle Mice

    Inhaled Carbon Monoxide: An Anti-Inflammatory Modulator in Transgenic Sickle Mice by Beckman, Joan D., Vineyard, Julie V., Yang, Casey, Schmidt, Thomas E., Belcher, John D., Vercellotti, Gregory M.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease

    Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease by BECKMAN, Joan D, BELCHER, John D, VINEYARD, Julie V, CHUNSHENG CHEN, NGUYEN, Julia, OSITA NWANERI, M, GERARD O'SULLIVAN, M, GULBAHCE, Evin, HEBBEL, Robert P, VERCELLOTTI, Gregory M

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: